Mark Boldrin

22 papers and 3.3k indexed citations i.

About

Mark Boldrin is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Molecular Biology. According to data from OpenAlex, Mark Boldrin has authored 22 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in Mark Boldrin’s work include Diabetes Treatment and Management (14 papers), Pharmacology and Obesity Treatment (13 papers) and Diabetes Management and Research (8 papers). Mark Boldrin is often cited by papers focused on Diabetes Treatment and Management (14 papers), Pharmacology and Obesity Treatment (13 papers) and Diabetes Management and Research (8 papers). Mark Boldrin collaborates with scholars based in United States, Switzerland and United Kingdom. Mark Boldrin's co-authors include Lars Sjöström, Jonathan Hauptman, Jarl Torgerson, Aila Rissanen, Michel Krempf, H. P. F. Koppeschaar, Teis Andersen, Alain Golay, Jean‐Pierre Chanoine and Craig L. Jensen and has published in prestigious journals such as The Lancet, JAMA and Diabetes Care.

In The Last Decade

Co-authorship network of co-authors of Mark Boldrin i

Fields of papers citing papers by Mark Boldrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Boldrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Boldrin. The network helps show where Mark Boldrin may publish in the future.

Countries citing papers authored by Mark Boldrin

Since Specialization
Citations

This map shows the geographic impact of Mark Boldrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Boldrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Boldrin more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2025